<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-10-01 21:56:23Autoimmune diseases Immunosuppressants Monoclonal antibodies Centocor Infliximab Schering-Plough Ulcerative colitis Colitis Clinical trial Health Medicine Pharmacology |
| Ixekizumab for moderate to severe chronic plaque psoriasisDocID: 1gyoS - View Document |
| 438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL-DocID: 1fNC6 - View Document |
| Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or RequirementDocID: 1a6Du - View Document |
| Infliximab (Remicade®) and Pregnancy In every pregnancy, a woman starts out with a 3-5% chance of having a baby with a birth defect. This is called her background risk. This sheet talks about whether exposure to inflixiDocID: 1a5mb - View Document |
| Microsoft Word - 106937148_19DocID: 19ODp - View Document |